Latest Insider Transactions at Adagio Therapeutics, Inc. (ADGI)
This section provides a real-time view of insider transactions for Adagio Therapeutics, Inc. (ADGI). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Adagio Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Adagio Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 29
2024
|
Terrance Mcguire |
SELL
Open market or private sale
|
Indirect |
112,381
-2.34%
|
$112,381
$1.66 P/Share
|
|
Jan 19
2024
|
Adimab, LLC |
SELL
Open market or private sale
|
Direct |
5,000,000
-18.74%
|
$15,000,000
$3.95 P/Share
|
|
Sep 01
2022
|
David Hering Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
8,000
+50.0%
|
$32,000
$4.52 P/Share
|
|
Aug 19
2022
|
Marc Elia |
BUY
Open market or private purchase
|
Indirect |
584,451
+5.94%
|
$2,337,804
$4.62 P/Share
|
|
Aug 18
2022
|
Marc Elia |
BUY
Open market or private purchase
|
Indirect |
1,265,549
+12.75%
|
$5,062,196
$4.31 P/Share
|
|
Aug 17
2022
|
Marc Elia |
BUY
Open market or private purchase
|
Indirect |
1,000,000
+11.91%
|
$4,000,000
$4.04 P/Share
|
|
Mar 03
2022
|
Adimab, LLC |
SELL
Other acquisition or disposition
|
Direct |
1,158,089
-4.16%
|
-
|
|
Aug 10
2021
|
Adimab, LLC |
BUY
Conversion of derivative security
|
Direct |
25,860,700
+48.15%
|
-
|
|
Aug 10
2021
|
Tillman U. Gerngross Chief Executive Officer |
BUY
Conversion of derivative security
|
Indirect |
25,860,700
+48.15%
|
-
|
|
Aug 10
2021
|
Terrance Mcguire |
BUY
Open market or private purchase
|
Indirect |
500,000
+9.81%
|
$8,500,000
$17.0 P/Share
|
|
Aug 10
2021
|
Terrance Mcguire |
BUY
Conversion of derivative security
|
Indirect |
8,031,700
+50.0%
|
-
|
|
Aug 10
2021
|
Mithril Ii LP > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
1,997,000
+15.08%
|
$33,949,000
$17.0 P/Share
|
|
Aug 10
2021
|
Mithril Ii LP > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
9,244,580
+50.0%
|
-
|
|
Aug 10
2021
|
Ajay Royan Director |
BUY
Open market or private purchase
|
Indirect |
1,997,000
+15.08%
|
$33,949,000
$17.0 P/Share
|
|
Aug 10
2021
|
Ajay Royan Director |
BUY
Conversion of derivative security
|
Indirect |
9,244,580
+50.0%
|
-
|
|
Aug 10
2021
|
Redmile Group, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
1,470,000
+30.24%
|
$24,990,000
$17.0 P/Share
|
|
Aug 10
2021
|
Redmile Group, LLC > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
1,920,960
+50.0%
|
-
|